Literature DB >> 27680696

Erratum: Replication fork stability confers chemoresistance in BRCA-deficient cells.

Arnab Ray Chaudhuri, Elsa Callen, Xia Ding, Ewa Gogola, Alexandra A Duarte, Ji-Eun Lee, Nancy Wong, Vanessa Lafarga, Jennifer A Calvo, Nicholas J Panzarino, Sam John, Amanda Day, Anna Vidal Crespo, Binghui Shen, Linda M Starnes, Julian R de Ruiter, Jeremy A Daniel, Panagiotis A Konstantinopoulos, David Cortez, Sharon B Cantor, Oscar Fernandez-Capetillo, Kai Ge, Jos Jonkers, Sven Rottenberg, Shyam K Sharan, André Nussenzweig.   

Abstract

Entities:  

Year:  2016        PMID： 27680696     DOI： 10.1038/nature19826

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Replication fork stability confers chemoresistance in BRCA-deficient cells.

Authors:  Arnab Ray Chaudhuri; Elsa Callen; Xia Ding; Ewa Gogola; Alexandra A Duarte; Ji-Eun Lee; Nancy Wong; Vanessa Lafarga; Jennifer A Calvo; Nicholas J Panzarino; Sam John; Amanda Day; Anna Vidal Crespo; Binghui Shen; Linda M Starnes; Julian R de Ruiter; Jeremy A Daniel; Panagiotis A Konstantinopoulos; David Cortez; Sharon B Cantor; Oscar Fernandez-Capetillo; Kai Ge; Jos Jonkers; Sven Rottenberg; Shyam K Sharan; André Nussenzweig
Journal:  Nature       Date:  2016-07-21       Impact factor: 49.962
  1 in total
  22 in total

Review 1.  Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition.

Authors:  Brittany Haynes; Junko Murai; Jung-Min Lee
Journal:  Cancer Treat Rev       Date:  2018-09-11       Impact factor: 12.111

2.  Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.

Authors:  Yu-Yi Chu; Mei-Kuang Chen; Yongkun Wei; Heng-Huan Lee; Weiya Xia; Ying-Nai Wang; Clinton Yam; Jennifer L Hsu; Hung-Ling Wang; Wei-Chao Chang; Hirohito Yamaguchi; Zhou Jiang; Chunxiao Liu; Ching-Fei Li; Lei Nie; Li-Chuan Chan; Yuan Gao; Shao-Chun Wang; Jinsong Liu; Shannon N Westin; Sanghoon Lee; Anil K Sood; Liuqing Yang; Gabriel N Hortobagyi; Dihua Yu; Mien-Chie Hung
Journal:  Nat Cancer       Date:  2022-10-17

Review 3.  PARP1: Structural insights and pharmacological targets for inhibition.

Authors:  Jacob O Spiegel; Bennett Van Houten; Jacob D Durrant
Journal:  DNA Repair (Amst)       Date:  2021-04-14

Review 4.  Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer.

Authors:  Ilaria Colombo; Stephanie Lheureux; Amit Manulal Oza
Journal:  Drug Des Devel Ther       Date:  2018-03-21       Impact factor: 4.162

5.  CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer.

Authors:  Elaine Sanij; Katherine M Hannan; Jiachen Xuan; Shunfei Yan; Jessica E Ahern; Anna S Trigos; Natalie Brajanovski; Jinbae Son; Keefe T Chan; Olga Kondrashova; Elizabeth Lieschke; Matthew J Wakefield; Daniel Frank; Sarah Ellis; Carleen Cullinane; Jian Kang; Gretchen Poortinga; Purba Nag; Andrew J Deans; Kum Kum Khanna; Linda Mileshkin; Grant A McArthur; John Soong; Els M J J Berns; Ross D Hannan; Clare L Scott; Karen E Sheppard; Richard B Pearson
Journal:  Nat Commun       Date:  2020-05-26       Impact factor: 14.919

6.  Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models.

Authors:  Hyoung Kim; Haineng Xu; Erin George; Dorothy Hallberg; Sushil Kumar; Veena Jagannathan; Sergey Medvedev; Yasuto Kinose; Kyle Devins; Priyanka Verma; Kevin Ly; Yifan Wang; Roger A Greenberg; Lauren Schwartz; Neil Johnson; Robert B Scharpf; Gordon B Mills; Rugang Zhang; Victor E Velculescu; Eric J Brown; Fiona Simpkins
Journal:  Nat Commun       Date:  2020-07-24       Impact factor: 14.919

Review 7.  Role of the Mre11 Complex in Preserving Genome Integrity.

Authors:  Julyun Oh; Lorraine S Symington
Journal:  Genes (Basel)       Date:  2018-11-29       Impact factor: 4.096

8.  EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2.

Authors:  Jadwiga Nieminuszczy; Ronan Broderick; Marina A Bellani; Elizabeth Smethurst; Rebekka A Schwab; Veronica Cherdyntseva; Theodora Evmorfopoulou; Yea-Lih Lin; Michal Minczuk; Philippe Pasero; Sarantis Gagos; Michael M Seidman; Wojciech Niedzwiedz
Journal:  Mol Cell       Date:  2019-06-26       Impact factor: 17.970

9.  AND-1 fork protection function prevents fork resection and is essential for proliferation.

Authors:  Takuya Abe; Ryotaro Kawasumi; Michele Giannattasio; Sabrina Dusi; Yui Yoshimoto; Keiji Miyata; Koyuki Umemura; Kouji Hirota; Dana Branzei
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

Review 10.  Integrating the DNA damage and protein stress responses during cancer development and treatment.

Authors:  Vassilis G Gorgoulis; Dafni-Eleftheria Pefani; Ioannis S Pateras; Ioannis P Trougakos
Journal:  J Pathol       Date:  2018-07-19       Impact factor: 7.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.